Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma

By Kast R.  

Journal of Neuro-Oncology, Vol. 94, Iss. 2, 2009-09 ,pp. : 163-167

Springer Publishing Company

Access to resources Recommend Favorite

Dlx-2 is implicated in TGF-β- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation

By                  

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1768-1780

Spandidos Publications

Access to resources Recommend Favorite

PAX6 suppresses growth of human glioblastoma cells

By Zhou Yi-Hong   Wu Xiaosong   Tan Fang   Shi Yue-Xi   Glass Tricia   Liu T.   Wathen Kyle   Hess Kenneth   Gumin Joy   Lang Frederick   Yung W.  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 65-77

Bentham Science Publishers

Access to resources Recommend Favorite

Hexane extract from Sargassum serratifolium inhibits the cell proliferation and metastatic ability of human glioblastoma U87MG cells

By              

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2602-2608

Spandidos Publications

Access to resources Recommend Favorite